Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Short-term Investments: 2010-2024

Historic Short-term Investments for Fresenius Medical Care AG (FMS) over the last 15 years, with Dec 2024 value amounting to $463.5 million.

  • Fresenius Medical Care AG's Short-term Investments rose 76.50% to $651.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $651.2 million, marking a year-over-year increase of 76.50%. This contributed to the annual value of $463.5 million for FY2024, which is 75.48% up from last year.
  • Per Fresenius Medical Care AG's latest filing, its Short-term Investments stood at $463.5 million for FY2024, which was up 75.48% from $264.1 million recorded in FY2023.
  • Fresenius Medical Care AG's Short-term Investments' 5-year high stood at $463.5 million during FY2024, with a 5-year trough of $4.0 million in FY2021.
  • For the 3-year period, Fresenius Medical Care AG's Short-term Investments averaged around $329.6 million, with its median value being $264.1 million (2023).
  • As far as peak fluctuations go, Fresenius Medical Care AG's Short-term Investments tumbled by 45.26% in 2021, and later skyrocketed by 6,361.07% in 2022.
  • Over the past 5 years, Fresenius Medical Care AG's Short-term Investments (MRY) stood at $7.4 million in 2020, then tumbled by 45.26% to $4.0 million in 2021, then surged by 6,361.07% to $261.3 million in 2022, then rose by 1.10% to $264.1 million in 2023, then surged by 75.48% to $463.5 million in 2024.
  • Its last three reported values are $463.5 million in FY2024, $264.1 million for FY2023, and $261.3 million during FY2022.